[Evaluation of the effectiveness of Vepeside (VP-16-213) in the treatment of drug-resistant recurrences of malignant lymphatic neoplasms].
Sliz
E
E
Pawlicki
M
M
Zuchowska-Vogelgesang
B
B
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004351:Drug Resistance; D005047:Etoposide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence
D005047:Etoposide
Ocena skuteczności Vepesidu (VP-16-213) w leczeniu chemioopornych nawrotów złośliwych nowotworów limfatycznych.